4,5-Dihydroxytryptamine
| 4,5-DHT | |
|---|---|
| Molecular structure drawn from PubChem coordinates |
| Physical properties [] | |
|---|---|
| Molecular mass | 192.21 g/mol [1] |
| Predicted LogP | 0.7 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C10H12N2O2 |
| IUPAC name | 3-(2-aminoethyl)-1H-indole-4,5-diol |
| SMILES | C1=CC(=C(C2=C1NC=C2CCN)O)O |
| InChI | InChI=1S/C10H12N2O2/c11-4-3-6-5-12-7-1-2-8(13)10(14)9(6)7/h1-2,5,12-14H,3-4,11H2 |
| InChIKey | HKPREGWFNPFQEA-UHFFFAOYSA-N |
| CAS number | 42241-03-2 |
| PubChem CID | 179537 |
4,5-Dihydroxytryptamine is a monoamine reuptake inhibitor and neurotoxin substance of the tryptamine class.
Chemistry
Stereochemistry []
4,5-Dihydroxytryptamine is achiral.
Druglikeness
Lipinski's rule of five
4,5-Dihydroxytryptamine matches Lipinski's rule of five.External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 179537, 4,5-Dihydroxytryptamine. Accessed November 20, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/179537
Data sources []
| Source | Status | Updated (UTC) |
|---|---|---|
| dosing | missing (no dosing statistics) | 2026-11-20 07:59:17 |
| drugspro | missing (no DrugsPRO reagent data) | 2026-11-20 07:59:13 |
| erowid | missing (no Erowid substance of that name) | 2026-11-20 07:59:13 |
| gsrs | missing (no UNII) | 2026-11-20 07:59:13 |
| hmdb | missing (no HMDB id) | 2026-11-20 07:59:13 |
| kegg | missing (no KEGG DRUG entry) | 2026-11-20 07:59:15 |
| pubchem | ok | 2026-11-20 07:59:13 |
| missing (no r/tripreports posts mention it) | 2026-11-20 07:59:14 | |
| sider | missing (not in SIDER) | 2026-11-20 07:59:13 |
| structure | ok | 2026-11-20 07:59:13 |
| wikipedia | ok | 2026-11-20 07:59:14 |